Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Theriva Biologics, Inc. (TOVX) had Income from Continuous Operations of $-4.32M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.32M |
|
-- |
|
-- |
|
$4.42M |
|
$-4.42M |
|
$0.09M |
|
$-4.32M |
|
$-4.32M |
|
$-4.32M |
|
|
Income from Continuous Operations |
$-4.32M |
$-4.32M |
|
$-4.32M |
|
$-4.42M |
|
$-4.39M |
|
2.78M |
|
2.78M |
|
$-1.55 |
|
$-1.55 |
|
| Balance Sheet Financials | |
$12.48M |
|
$0.25M |
|
$19.68M |
|
$32.16M |
|
$8.15M |
|
$1.50M |
|
$8.52M |
|
$16.66M |
|
$15.50M |
|
$15.50M |
|
$15.50M |
|
2.78M |
|
| Cash Flow Statement Financials | |
$-4.76M |
|
-- |
|
$3.07M |
|
$11.71M |
|
$10.11M |
|
$-1.59M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.90% |
|
-27.90% |
|
-13.44% |
|
-25.43% |
|
$5.57 |
|
$-1.71 |
|
$-1.71 |
|